Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 32% ± 14% | |
| oligodendrocyte precursor cell | 10 studies | 37% ± 17% | |
| astrocyte | 9 studies | 38% ± 17% | |
| oligodendrocyte | 8 studies | 37% ± 17% | |
| type I pneumocyte | 6 studies | 27% ± 11% | |
| GABAergic neuron | 6 studies | 34% ± 17% | |
| epithelial cell | 6 studies | 31% ± 12% | |
| type II pneumocyte | 6 studies | 29% ± 10% | |
| fibroblast | 6 studies | 22% ± 7% | |
| interneuron | 5 studies | 41% ± 22% | |
| neuron | 5 studies | 40% ± 17% | |
| endothelial cell of artery | 4 studies | 30% ± 18% | |
| glutamatergic neuron | 4 studies | 44% ± 20% | |
| retinal pigment epithelial cell | 4 studies | 31% ± 9% | |
| club cell | 4 studies | 27% ± 10% | |
| endothelial cell of lymphatic vessel | 4 studies | 28% ± 4% | |
| glial cell | 3 studies | 28% ± 7% | |
| granule cell | 3 studies | 20% ± 1% | |
| microglial cell | 3 studies | 23% ± 5% | |
| pericyte | 3 studies | 25% ± 7% | |
| ciliated cell | 3 studies | 22% ± 7% | |
| Mueller cell | 3 studies | 31% ± 17% | |
| hepatocyte | 3 studies | 61% ± 15% | |
| connective tissue cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 38% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 3357.98 | 245 / 245 | 100% | 15.28 | 500 / 502 |
| brain | 100% | 2001.92 | 2638 / 2642 | 100% | 19.68 | 702 / 705 |
| pancreas | 100% | 2310.40 | 328 / 328 | 99% | 12.17 | 176 / 178 |
| esophagus | 100% | 2302.42 | 1444 / 1445 | 99% | 19.35 | 181 / 183 |
| breast | 100% | 3832.70 | 459 / 459 | 99% | 21.36 | 1104 / 1118 |
| lung | 100% | 3818.27 | 578 / 578 | 99% | 15.44 | 1140 / 1155 |
| intestine | 100% | 3266.37 | 966 / 966 | 98% | 13.58 | 519 / 527 |
| ovary | 100% | 4198.91 | 180 / 180 | 98% | 16.37 | 423 / 430 |
| stomach | 100% | 2316.59 | 359 / 359 | 98% | 16.22 | 280 / 286 |
| liver | 100% | 3409.07 | 226 / 226 | 98% | 13.35 | 396 / 406 |
| adrenal gland | 100% | 1702.69 | 258 / 258 | 97% | 10.52 | 223 / 230 |
| thymus | 100% | 3794.70 | 653 / 653 | 96% | 12.62 | 583 / 605 |
| skin | 100% | 2585.56 | 1807 / 1809 | 96% | 18.43 | 452 / 472 |
| kidney | 100% | 2201.79 | 89 / 89 | 95% | 13.86 | 860 / 901 |
| bladder | 100% | 2856.62 | 21 / 21 | 95% | 10.25 | 479 / 504 |
| uterus | 100% | 5687.93 | 170 / 170 | 92% | 11.85 | 423 / 459 |
| adipose | 100% | 2814.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3426.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1816.60 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.40 | 1 / 1 |
| heart | 97% | 1538.96 | 838 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 10.99 | 42 / 45 |
| spleen | 87% | 783.34 | 210 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 76% | 6.14 | 61 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.72 | 5 / 29 |
| peripheral blood | 9% | 86.77 | 82 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072659 | Biological process | protein localization to plasma membrane |
| GO_0006897 | Biological process | endocytosis |
| GO_0043434 | Biological process | response to peptide hormone |
| GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
| GO_1904948 | Biological process | midbrain dopaminergic neuron differentiation |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0034392 | Biological process | negative regulation of smooth muscle cell apoptotic process |
| GO_0060070 | Biological process | canonical Wnt signaling pathway |
| GO_0071542 | Biological process | dopaminergic neuron differentiation |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0071397 | Biological process | cellular response to cholesterol |
| GO_0014029 | Biological process | neural crest formation |
| GO_0014033 | Biological process | neural crest cell differentiation |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0007399 | Biological process | nervous system development |
| GO_0045787 | Biological process | positive regulation of cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0071901 | Biological process | negative regulation of protein serine/threonine kinase activity |
| GO_1990851 | Cellular component | Wnt-Frizzled-LRP5/6 complex |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0005769 | Cellular component | early endosome |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0009986 | Cellular component | cell surface |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0045202 | Cellular component | synapse |
| GO_1990909 | Cellular component | Wnt signalosome |
| GO_0005901 | Cellular component | caveola |
| GO_0017147 | Molecular function | Wnt-protein binding |
| GO_0015026 | Molecular function | coreceptor activity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005109 | Molecular function | frizzled binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0019210 | Molecular function | kinase inhibitor activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0042813 | Molecular function | Wnt receptor activity |
| GO_0019534 | Molecular function | toxin transmembrane transporter activity |
| GO_0005041 | Molecular function | low-density lipoprotein particle receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRP6 |
| Protein name | Low-density lipoprotein receptor-related protein 6 (LRP-6) Low-density lipoprotein receptor-related protein LDL receptor related protein 6 (Low-density lipoprotein receptor-related protein 6) |
| Synonyms | |
| Description | FUNCTION: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalosomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation (By similarity). . FUNCTION: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. . FUNCTION: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. . |
| Accessions | ENST00000543091.1 ENST00000625211 O75581 H0YGH0 ENST00000626957 ENST00000535731.1 F5H7J9 ENST00000626698 F5H0Z3 ENST00000626182 B7ZLD0 ENST00000540527.5 H0YGW5 ENST00000538239.5 ENST00000261349.9 ENST00000628182.3 |